Acadia promotes Schneyer to CFO

Neuroscience company Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) promoted Mark Schneyer to EVP and CFO. Schneyer, who was head of BD and CBO, has served as interim CFO since Elena Ridloff left the company on Sept. 10. Schneyer joined Acadia in 2020 from Pfizer Inc. (NYSE:PFE), where he was VP of business development for the pharma’s Upjohn division.

Iveric bio Inc. (NASDAQ:ISEE) hired Tony Gibney as EVP and chief business and strategy officer. Gibney was previously CFO and CBO at Fog Pharmaceuticals. Iveric is developing treatments for retinal diseases...